Predicting treatment responses and disease progression in myeloma using serum vascular endothelial growth factor and hepatocyte growth factor levels

Leukemia and Lymphoma

Volumn 44, Issue 8, 2003, Pages 1275-1279

  Iwasaki, Tsuyoshi ^a   Sano, Hajime ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Amyloidosis; Angiogenesis; Hepatocyte growth factor; Multiple myeloma; Vascular endothelial growth factor

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; BASIC FIBROBLAST GROWTH FACTOR; CYTOKINE; INTERLEUKIN 6; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; THALIDOMIDE; TUMOR MARKER; VASCULOTROPIN; VASCULOTROPIN A;

AMYLOIDOSIS; ANGIOGENESIS; AUTOCRINE EFFECT; BLOOD; BONE MARROW CELL; CELL ISOLATION; CELL PROLIFERATION; CELL SECRETION; CELL STIMULATION; DISEASE COURSE; ENDOTHELIUM CELL; HOSPITALIZATION; HUMAN; MORTALITY; MULTIPLE MYELOMA; NEOVASCULARIZATION (PATHOLOGY); PARACRINE SIGNALING; PLASMACYTOMA; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; REVIEW; STROMA CELL; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM;

HEPATOCYTE GROWTH FACTOR; HUMANS; MULTIPLE MYELOMA; PROGNOSIS; SEVERITY OF ILLNESS INDEX; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 0038127223     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/1042819031000079113     Document Type: Review

References (44)

1. Folkman, J. (1971) "Tumor angiogenesis: therapeutic implications", N. Engl. J. Med 285, 1182-1186.
2. Folkman, J. (1995) "Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis", N. Engl. J. Med 333,1757-1763.
3. Folkman, J. (1996) "New perspectives in clinical oncology from angiogenesis research", Eur. J. Cancer 32A, 2534-2539.
4. Weidner, N., Semple, J.P., Welch, W.R. and Folkman, J. (1991) "Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma", N. Engl. J. Med. 324, 1-8.
5. Fox, S.B. (1997) "Tumor angiogenesis and prognosis", Histopathology 30, 294-301.
6. Salven, P., Teerenhovi, L. and Joensuu, H. (1999) "A high pretreatment serum basic fibroblast growth factor concentration is an independent predictor of poor prognosis in non-Hodgkin's lymphoma", Blood 94, 3334-3339.
7. Perez-Atayde, A.R., Sallan, S.E., Tedrow, U., Connors, S., Allred, E. and Folkman, J. (1997) "Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia", Am. J. Pathol. 150, 815-821.
8. Vacca, A., Di Loreto, M., Di Stefano, R., Gadaleta-Caldarola, G., Iodice, G., Caloro, D. and Dammacco, F. (1995) "Bone marrow of patients with active multiple myeloma: angiogenesis and plasma cell adhesion molecules LFA-1, VLA-4, LAM-1 and CD44", Am. J. Hematol. 50, 9-14.
9. Rajkumar, S.V., Leong, T., Roche, P.C., Fonseca, R., Dispenzieri, A., Lacy, M.Q., Lust, J.A., Witzig, T.E., Kyle, R.A., Gertz, M.A. and Greipp, P.R. (2000) "Prognostic value of bone marrow angiogenesis in multiple myeloma", Clin. Cancer Res. 6, 3111-3116.
10. Claffey, K.P. and Robinson, G.S. (1996) "Regulation of VEGF/VPF expression in tumor cells: consequences for tumor growth and metastasis", Cancer Metastasis Rev. 15, 165-176.
11. Claffey, K.P., Brown, L.F., del Aguila, L.F., Tognazzi, K., Yeo, K.T., Manseau, E.J. and Dvorak, H.F. (1996) "Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis", Cancer Res. 56, 172-181.
12. Folkman, J. (1995) "Angiogenesis in cancer, vascular, rheumatoid and other disease", Nat. Med 1, 27-31.
13. Kim, K.J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H.S. and Ferrara, N. (1993) "Inhibition of vascular endothelial growth factor induced angiogenesis suppresses tumor growth in vivo", Nature 362, 841- 844.
14. Dankbar, B., Padro, T., Leo, R., Feldmann, B., Kropff, M., Mesters, R.M., Serve, H., Berdel, W.E. and Kienast, J. (2000) "Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stroma cell interactions in multiple myeloma", Blood 95, 2630-2636.
15. Podar, K., Tai, Y.T., Davies, F.E., Lentzsch, S., Sattler, M., Hideshima, T., Lin, B.K., Gupta, D., Shima, Y, Chauhan, D., Mitsiades, C., Raje, N., Richardson, P. and Anderson, K.C. (2001) "Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration", Blood 98, 428-435.
16. Bussolino, F., Di Renzo, M.F., Ziche, M., Bocchietto, E., Olivero, M., Naldini, L., Gaudino, G., Tamagnone, L., Coffer, A. and Comoglio, P.M. (1992) "Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth", J. Cell. Biol. 119, 629-641.
17. Stoker, M., Gherardi, E., Perryman, M. and Gray, J. (1987) "Scatter factor is a fibroblast derived modulator of epithelial cell mobility", Nature 327, 239-242.
18. Taniguchi, T., Toi, M., Inada, K., Imazawa, T., Yamamoto, Y. and Tominaga, T. (1995) "Serum concentrations of hepatocyte growth factor in breast cancer patients", Clin. Cancer Res. 1, 1031-1034.
19. Borest, M., Lien, E., Espevik, T., Helseth, E., Waage, A. and Sundan, A. (1996) "Concomitant expression of hepatocyte growth factor/scatter factor and the receptor c-MET in human myeloma cell lines", J. Biol. Chem. 271, 24655-24661.
20. Borest, M., Hjorth-Hansen, H., Seidel, C., Sundan, A. and Waage, A. (1996) "Hepatocyte growth factor and its receptor c-met in multiple myeloma", Blood 88, 3998-4004.
21. Banks, R.E., Forbes, M.A., Kinsey, S.E., Stanley, A., Ingham, E., Walters, C. and Selby, P.J. (1998) "Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology", Br. J. Cancer 77, 956-964.
22. Gaudry, M., Bregerie, O., Andvieu, V., El Benna, J., Pocidalo, M.A. and Hakim, J. (1997) "Intracellular pool of vascular endothelial growth factor in human neutrophils", Blood 90, 4153 -4161.
23. Sakon, M., Kita, Y., Takeda, Y., Higaki, N., Ohzato, H., Umeshita, K., Hasuike, Y., Gotoh, M. and Monden, M. (1999) "Measurement of hepatocyte growth factor in serum and plasma", Int. J. Clin. Lab. Res. 29,110-113.
24. Aguayo, A., Estey, E., Kantarjian, H., Mansouri, T., Gidel, C., Keating, M., Giles, F., Estrov, Z., Barlogie, B. and Albitar, M. (1999) "Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia", Blood 94, 3717-3721.
25. Nakamura, S., Gohda, E., Matsuo, Y., Yamamoto, I. and Minowada, J. (1994) "Significant amount of hepatocyte growth factor detected in blood and bone marrow plasma of leukemia patients", Br J. Haematol. 87, 640-642.
26. Hjorth-Hansen, H., Seidel, C., Lamvik, J., Borset, M., Sundan, A. and Waage, A. (1999) "Elevated serum concentrations of hepatocyte growth factor in acute myelocytic leukemia", Eur. J. Haematol. 62, 129-134.
27. Verstovsek, S., Kantarjian, H., Estey, E., Aguayo, A., Giles, F.J., Manshouri, T., Koller, C., Estrov, Z., Freireich, E., Keating, M. and Albitar, M. (2001) "Plasma hepatocyte growth factor is a prognostic factor in patients with acute myeloid leukemia but not in patients with myelodysplastic syndrome", Leukemia 15, 1165-1170.
28. Salven, P., Teerenhovi, L. and Joensuu, H. (1997) "A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma", Blood 90, 3167-3172.
29. Teofili, L., Di Febo, A.L., Peirconti, F., Maggiano, N., Bendandi, M., Rutella, S., Cingolani, A., Di Renzo, N., Musto, P., Pileri, S., Leone, G. and Larocca, L.M. (2001) "Expression of the c-met proto-oncogene and its ligand, hepatocyte growth factor, in Hodgkin disease", Blood 97, 1063 -1069.
30. Seidel, C., Borest, M., Turesson, I., Abildgaard, N., Sundan, A. and Waage, A. (1998) "Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma. The Nordic Myeloma Study Group", Blood 91, 806-812.
31. Watanabe, O., Arimura, K., Kitajima, I., Osame, M. and Maruyama, I. (1996) "Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome (letter)", Lancet 347, 702.
32. Soubrier, M., Dubost, J.J., Serre, A.F., Ristori, J.M., Sauvezie, B., Cathebras, P., Piette, J.C., Chapman, A., Authier, F.J. and Gherardi, R.K. (1997) "Growth factor in POEMS syndrome: evidence for a marked increase in circulating vascular endothelial growth factor", Arthritis Rheum. 40, 786-787.
33. Soubrier, M., Dubost, J.J. and Sauvezie, B. (1994) "POEMS syndrome: a study of 25 cases and a review of the literature. French Study Group on POEMS syndrome", Am. J. Med. 97, 543-553.
34. Di Raimond, F., Azzaro, M.P., Plaumbo, G.A., Bagnato, S., Giustolisi, G., Floridia, P., Sortino, G. and Giustolisi, R. (2000) "Angiogenic factors in multiple myeloma: high levels in bone marrow than in peripheral blood", Haematologica 85, 800-805.
35. Iwasaki, T., Hamano, T., Ogata, A., Hashimoto, N., Kitano, M. and Kakishita, E. (2002) "Clinical significance of vascular endothelial growth factor and hepatocyte growth factor in multiple myeloma", Br. J. Haematol. 116, 796-802.
36. Sezer, O., Jakob, C., Eucker, J., Niemoller, K., Gatz, F., Wernecke, K. and Possinger, K. (2001) "Serum levels of the angiogenic cytokines basic fibroblastic growth factor (bFGF), vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in multiple myeloma", Eur. J. Haematol. 66, 83-88.
37. Shikano, M., Kushimoto, H., Hasegawa, H., Tomita, M., Hasegawa, M., Murakami, K. and Kawashima, S. (2000) "Usefullness of serum hepatocyte growth factor for the diagnosis of amyloidosis", Intern. Med. 39, 715-719.
38. Martiny-Baron, G. and Marme, D. (1995) "VEGF-mediated tumor angiogenesis: a new target for cancer therapy", Curr. Opin. Biotechnol. 6, 675-680.
39. Thomas, K.A. (1996) "Vascular endothelial growth factor, a potent and selective angiogenic agent", J. Biol. Chem. 271, 603-606.
40. Singhal, S., Mehta, J., Desikan, R., Ayers, D., Roberson, R, Eddlemon, P., Munshi, N., Anaissie, E., Wilson, C., Dhodapkar, M., Zeddis, J. and Barlogie, B. (1999) "Antitumor activity of thalidomide in refractory multiple myeloma", N. Engl. J. Med. 341, 1565-1571.
41. Dmoszynska, A., Bojarska-Junak, A., Domanski, D., Rolinski, J., Hus, M. and Soroka-Wojtaszko, M. (2002) "Production of proangiogenic cytokines during thalidomide treatment of multiple myeloma", Leuk. Lymphoma 43,401-406.
42. Neben, K., Moehler, T., Kraemer, A., Benner, A., Egerer, G., Ho, A.D. and Goldschmidt, H. (2001) "Response to thalidomide in progressive multiple myeloma is not mediated by inhibition of angiogenic cytokine secretion", Br. J. Haematol. 115, 605-608.
43. Kmiecik, T.E., Keller, J.R., Rosen, E. and Vande Woude, G.F. (1992) "Hepatocyte growth factor is a synergistic factor for the growth of hematopoietic progenitor cells", Blood 80, 2454-2457.
44. Takai, K., Hara, J., Matsumoto, K., Hosoi, G., Osugi, Y., Tawa, A., Okada, S. and Nakamura, T. (1997) "Hepatocyte growth factor is constitutively produced by human bone marrow stromal cells and indirectly promotes hematopoiesis", Blood 89, 1560-1565.